# No disease left behind

**Authors:** Muzamil Arshad, Connor Lynch, Rohan R. Katipally, Sean P. Pitroda, Ralph R. Weichselbaum

PMC · DOI: 10.18632/oncotarget.28700 · Oncotarget · 2025-03-13

## Full-text entities

- **Genes:** KLK3 (kallikrein related peptidase 3) [NCBI Gene 354] {aka APS, KLK2A1, PSA, hK3}
- **Diseases:** RCC (MESH:D002292), pancreatic cancer (MESH:D010190), lung fibrosis (MESH:D005355), cervical cancer (MESH:D002583), DM (MESH:D009362), Tumor (MESH:D009369), HCC (MESH:D006528), rectal cancer (MESH:D012004), Rectal adenocarcinomas (MESH:D000230), lung cancer (MESH:D008175), LF (MESH:D051437), prostate cancer (MESH:D011471), NSCLC (MESH:D002289), anal cancer (MESH:D001005), Anal squamous cell carcinoma (MESH:D002294), prostate (MESH:D011472)
- **Chemicals:** nivolumab (MESH:D000077594), SABR (-)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC11906142/full.md

## Figures

1 figure with captions in the complete paper: https://tomesphere.com/paper/PMC11906142/full.md

## References

46 references — full list in the complete paper: https://tomesphere.com/paper/PMC11906142/full.md

---
Source: https://tomesphere.com/paper/PMC11906142